Cardinal Health announced the opening of a single-use medical device remanufacturing facility in Beresfield, Newcastle, set to launch in late 2025.
Unveiled at the Health Innovation Living Lab at the John Hunter Hospital on 18 March, it will be Cardinal Health’s first remanufacturing facility outside of the United States.
The new facility will play a crucial role in enhancing Australia’s sovereign manufacturing capability in healthcare. It aligns with the country’s Environmental, Social, and Governance (ESG) efforts by significantly reducing medical waste and landfill impact. The facility will utilise a TGA-approved cleaning and disinfection process to remove soil, contamination and bioburden from single-use medical devices. They then undergo functionality and quality testing, before being returned to hospitals for reuse, rather than contributing to landfill.
Remanufacturing offers a significant opportunity to strengthen Australia’s health technology manufacturing capabilities. A well-established industry in the U.S., it has shown to substantially reduce the environmental impact of hospitals and medical device usage.
The Invest Regional team provided support to Cardinal Health in the following ways:
- drove understanding of key investment decision drivers and the provision of relevant information
- reviewed potential regional NSW sites to support Cardinal Health’s research and due diligence process
- introduced industry networks to ensure strategic investment
- scoped Targeted Workforce Development to assist with recruitment and workforce development objectives.